2 studies found for:    RETINITIS PIGMENTOSA 34
Show Display Options
Rank Status Study
1 Enrolling by invitation Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy
Conditions: Non-exudative Age-related Macular Degeneration;   Diabetic Retinopathy;   Retina Vein Occlusion;   Retinitis Pigmentosa;   Hereditary Macular Degeneration
Intervention: Drug: CD34+ bone marrow stem cells intravitreal
2 Recruiting Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Biological: Stem Cell Transplantation

Indicates status has not been verified in more than two years